Aravind Palraj / X
Jul 22, 2025, 09:17
Decoding Antiphospholipid Syndrome: Why Triple Positivity Is a Red Flag for Thrombosis
Aravind Palraj, MD highlights a crucial message on his X page:
”Antiphospholipid antibodies (aPL) are key to diagnosing APS—but timing, type, and persistence matter.
Triple positive? Highest thrombosis risk.
Test smart. Interpret wisely.”
Want to dive deeper into Antiphospholipid Syndrome?
On Hemostasis Today, you can explore in-depth, clinically relevant, and first-hand academic knowledge on:
- Diagnostic strategies for APS
- Role of Lupus Anticoagulant, anticardiolipin, and β2-GPI antibodies
- Risk stratification and management approaches in triple-positive patients
- Anticoagulation dilemmas in APS
-
Sep 8, 2025, 07:48Andreas Zirlik Announces EAS Rare Lipid Disorders Course at 7th Cardio Summit Graz
-
Sep 8, 2025, 06:22Noa Kabera Joins EAHAD as Project Coordinator to Advance Haemophilia and Allied Disorders Care
-
Sep 7, 2025, 16:14Paddy Barret on Thin Cap Fibroatheroma's Outcomes
-
Sep 7, 2025, 14:17Edina Cenko Shares Lancet Regional Health Series on Inequalities in Cardiovascular Care
-
Sep 7, 2025, 14:04Pedal Circulation Status Found Crucial for Wound Healing in Chronic Limb-Threatening Ischemia
-
Sep 8, 2025, 14:22GLP-1 Receptor Agonists and Cardiovascular Benefits․ Role of Clinical Features
-
Sep 8, 2025, 14:21Hamza A. Salim: CTA Collateral Impairment Score Enhances Stroke Prognosis Accuracy
-
Sep 7, 2025, 17:19Tessa Jaspers and Colleagues on Current Evidence Not Supporting Routine Anti-Xa Monitoring in Use of LMWH
-
Sep 7, 2025, 14:11New RPTH Journal Research: Statins Reduce Thrombosis Risk but Not Severity of Pulmonary Embolism
-
Sep 7, 2025, 13:37Unfractionated Heparin Dosing in ECMO: A Systematic Review and Meta-Analysis
-
Sep 8, 2025, 14:24Von Willebrand Factor as a Therapeutic Target․ From Development to Clinical Application
-
Sep 7, 2025, 14:16Mary Kiige: Biological Hemoglobin Oxygen Carrier as a Lifesaving Oxygen Bridge
-
Sep 7, 2025, 14:13Breakthrough in Blood: Cécile Denis and INSERM Team Develop Nanobody Therapy for Type 1 VWD
-
Sep 2, 2025, 13:53Cost-Effective Strategies to Reduce Anaemia Highlighted in The Lancet Haematology
-
Sep 2, 2025, 13:04Ischemic Stroke or TIA Linked to Higher Femoral Fracture Risk
-
Sep 8, 2025, 15:10Michael Makris on WHO’s Essential Medicines List Update: A Win for the Global Haemophilia Community
-
Sep 8, 2025, 14:26European Haemophilia Consortium Marks World PT Day: Physiotherapy Empowers People with Bleeding Disorders
-
Sep 8, 2025, 07:03Omar Adwan Explains the Key Difference Between Serum and Plasma
-
Sep 8, 2025, 05:27Kerry Bozza Funkhouser at BIC 2025 Roundtable on Heavy Menstrual Bleeding and Rare Bleeding Disorders
-
Sep 7, 2025, 17:30Louise Bannon Invites You To Join The ''Blood Clot Busters'' Series Uncovering The Truth About Thrombosis
Sep 8, 2025, 07:03